Literature DB >> 12376218

Outcome of percutaneous nephrostomy for the management of pyonephrosis.

C K Ng1, S K H Yip, L S J Sim, B H Tan, M Y C Wong, B S Tan, A Htoo.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the efficacy of percutaneous nephrostomy (PCN) drainage for the interim management of pyonephrosis.
METHODS: Ninety-two consecutive patients [29 men, 63 women; mean age, 57 years; range, 23 to 88] who underwent PCN for the treatment of pyonephrosis from 1996 to 1999 were evaluated retrospectively. The clinical presentation, bacteriology and patient outcomes were analyzed.
RESULTS: The majority [77%] of patients had underlying obstructing urinary calculi. Other causes of obstruction included strictures [9%], papillary necrosis [7%], pelvi-ureteric junction obstruction [4%] and malignant stricture [3%]. The microorganisms cultured were Escherichia coli [30%], Klebsiella [19%], Proteus [8%], Pseudomonas [5%], Enterococcus [5%], and Candida spp [5%]. The microorganisms were sensitive to gentamicin [79%], ceftriaxone [71%], cephalexin [54%], nitrofurantoin [40%], cotrimoxazole [35%], nalidixic acid [32%] and ampicillin [29%]. Only 30% of bladder urine cultures were positive for microorganisms; the addition of PCN cultures improved this yield to 58%. The antibiotic regimen was revised according to the PCN culture whenever there was a discrepancy. After PCN, 69% of patients underwent minimally invasive procedures as definitive treatment of the obstructing lesion. Only 14% of patients required open surgery. There was low procedure-related morbidity [14%] and low overall mortality [2%].
CONCLUSIONS: PCN cultures yield important bacteriological information. The procedure is associated with minimal morbidity, facilitates definitive treatment and provides therapeutic benefit.

Entities:  

Mesh:

Year:  2002        PMID: 12376218     DOI: 10.1016/S1015-9584(09)60178-0

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  9 in total

1.  Single session removal of forgotten encrusted ureteral stents: combined endourological approach.

Authors:  Ahmet Ali Sancaktutar; Haluk Söylemez; Yaşar Bozkurt; Tayfun Oktar
Journal:  Urol Res       Date:  2012-01-13

Review 2.  Management of dysfunctional catheters and tubes inserted by interventional radiology.

Authors:  Steven Y Huang; Bjorn I Engstrom; Matthew P Lungren; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 3.  Emergent Percutaneous Nephrostomy for Pyonephrosis: A Primer for the On-Call Interventional Radiologist.

Authors:  Christopher Florido; Josi L Herren; Mithil B Pandhi; Matthew M Niemeyer
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

4.  A novel comprehensive predictive model for obstructive pyonephrosis patients with upper urinary tract stones.

Authors:  Xinguang Wang; Kun Tang; Ding Xia; Ejun Peng; Rui Li; Hailang Liu; Zhiqiang Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

5.  One-stage tubeless antegrade ureteric stenting: a safe and cost-effective option?

Authors:  Sudhanshu Chitale; Vaiyapuri Raja; Nabeel Hussain; Janak Saada; Simon Girling; Stuart Irving; J F Cockburn
Journal:  Ann R Coll Surg Engl       Date:  2009-12-07       Impact factor: 1.891

Review 6.  Primary neonatal MRSA pyonephrosis.

Authors:  Ramnik Patel; Ngozi Nwokoma; George K Ninan
Journal:  Int Urol Nephrol       Date:  2012-08-21       Impact factor: 2.370

7.  Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection.

Authors:  Silke Schelenz; Calum N Ross
Journal:  BMC Infect Dis       Date:  2006-08-08       Impact factor: 3.090

Review 8.  Xanthogranulomatous pyelonephritis infected with the Providencia stuartii: a case report and literature review.

Authors:  Zhunan Xu; Tong Cai; Xuebao Zhang; Jitao Wu; Chu Liu
Journal:  BMC Nephrol       Date:  2021-10-29       Impact factor: 2.388

9.  Effects of renal pelvic high-pressure perfusion on nephrons in a porcine pyonephrosis model.

Authors:  Jian Wang; DA-Qing Zhou; Meng He; Wen-Gang Li; Xiang Pang; Xiao-Xiang Yu; Bo Jiang
Journal:  Exp Ther Med       Date:  2013-03-21       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.